DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

33
DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS 06/16/22 L15-16 1 PRINCE SATTAM BIN ABDUL AZIZ UNIVERSITY COLLEGE OF PHARMACY Nuclear Pharmacy Nuclear Pharmacy ( ( PHT 433 PHT 433 ) ) Dr. Shahid Jamil Dr. Shahid Jamil

description

Dosage Forms of Radiopharmaceutics Solid sources of Radiation: Small Solid sources of Radiation are used for direct implantation into tumours. This has been done for many years with 226Ra and the scope of the technique has been greatly extended by the availability of artificial radionuclides. Removable applicators are used for intracavitary irradiation of the nasopharynx (90Sr), oesophagus 60Co), uterus(137Cs,60Co), bladder (182Ta) and cervix (126Ra). 4/27/2017 L15-16

Transcript of DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

Page 1: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

DOSAGE FORMS AND APPLICATION OF

RADIOPHARMACEUTICS

05/04/23 L15-16 1

PRINCE SATTAM BIN ABDUL AZIZ UNIVERSITYCOLLEGE OF PHARMACY

Nuclear PharmacyNuclear Pharmacy((PHT 433PHT 433 ) )

Dr. Shahid JamilDr. Shahid Jamil

Page 2: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

Solid sources of Radiation: Small Solid sources of Radiation are used for direct implantation into tumours. This has been done for many years with 226Ra and the scope of the technique has been greatly extended by the availability of artificial radionuclides. Removable applicators are used for intracavitary irradiation of the nasopharynx (90Sr), oesophagus 60Co), uterus(137Cs,60Co), bladder (182Ta) andcervix (126Ra).

Dosage Forms of Radiopharmaceutics

05/04/23 2L15-16

Page 3: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

Solutions:Including solutions of radiopharmaceuticals for oral administration which is sterile and contain a bacteriostatic or consist of sterile apyrogenic solutions for parenteral use, in single- or multiple- dose vials.Only two radionuclides are widely used in solution form. Thyroid cancer may be treated with 131I, The irradiation of blood-forming tissues by 32P fromabsorption sites in bone is the method of choice in the treatment of polycythaemia vera, an excessive production of red cells, and may also be useful in the treatment of myeloid and lymphatic leukaemias, which are characterized by excessive white cell production.

05/04/23 3L15-16

Page 4: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

Colloids:Colloidal suspensions of appropriate particle size

(10-500 nm) remain located in body cavities or in

tissues of low vascularity,

this principle is utilized primarily for treatment of

the peritoneal and pleural cavities with colloids of

gold 198Au and 90Y.

These colloids can also be used in the bladder to

treatment of diffuse growths.

05/04/23 4L15-16

Page 5: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

Microspheres

which are spherical aggregates (0.5-50 μm),

generally produced by heat denaturation of

biodegradable substances. They are normally

suspended in sterile normal parenteral injection and

used for, specific capillary blockade.

05/04/23 5L15-16

Page 6: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

Hard gelatin Capsules

Either containing some solid in which is absorbed the radiopharmaceutical, or having the radio pharmaceutical evaporated on the inner surface, as in the case of sodium iodide 131 I. Oily liquid radiopharmaceuticals are dispensed in this manner.

05/04/23 6L15-16

Page 7: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

ContainersWhether radiopharmaceuticals are supplied as single dose or multidose preparations, the most common container is the 10mL rubber - capped multidose vial.Although glass ampoules are regarded as ideal containers for single dose non-radioactive injections, they are not considered ideal for radiopharmaceuticals due to the potential for radioactive contamination while being opened.

05/04/23 7L15-16

Page 8: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

Labelling of ContainersThe lable for a radiopharmaceutical should state:

The name of the radiopharmaceutical.The route of administration.The activity in the container.The time and date at which the radiopharmaceutical will have the stated activity.The volume, if the radiopharmaceutical is in liquid formThe lot numberThe expiry dateThe name and concentration of any added substances.Any special instructions such as " Shake well before use".Any special storage conditionsThe name of the supplierThat the preparation is radioactive.

05/04/23 8L15-16

Page 9: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

Radioisotopes are used in medicine in two different ways. They may be used as:(1) Radiation sources, or(2) Radioactive tracers.

As radiation sources Their principal role is in therapy. The choice of the isotope for a given application is governed by the properties of the radiation required for treatment; type and energy of the radiation and range in tissues.

Medical Applications of Radioisotopes

05/04/23 9L15-16

Page 10: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

As a radioactive tracer The chemical identity and form of the nuclide are most important since the tracer must be isotopic with the element being traced or must otherwise be capable of being incorporated as a part of a particular molecule.The nature of the radiation emitted by a tracer radioisotope is important for its ease of detection. Radioactive tracers are used in medicine principally for diagnostic purposes.

05/04/23 10L15-16

Page 11: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

I- Therapeutic applications of

radioisotopesFor therapy, isotopes are used as radiation sources, not as tracers. Their therapeutic use is basically justified by the fact that radioactive material, when present in a tissue or organ in sufficient quantity, will produce emanation capable of destroying existing cells and preventing the formation of new tissue. For this reason isotopic therapy is generally applied only to those diseases in which there exists extensive cellular metabolic or to those conditions in which an organ or tissue produces physiological harm through overactivity.

05/04/23 11L15-16

Page 12: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

The radioisotopes as radiation sources for therapy may be used either externally or internally. Where radioisotopes are used as external sources or as sealed sources implanted in a tissue, the dose is terminated by removal of the source. When they are administered internally as an unsealed source, the dose administered to the patient, either in therapy or in diagnosis, cannot be terminated by removal of the source. In therapeutic applications the total dose must be calculated for knowledge of the effective half - life of the isotope, the type and energy of the radiation emitted, and the concentration of the isotope in the tissue.

05/04/23 12L15-16

Page 13: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

A. External Sources1. Teletherapy units containing 60Co or of 137 Cs have

been used for the treatment of lesions.2. Surface sources for dermatologic and ophthalmologic

work consisting of applicators containing pure beta emitters such as 32 P and 90Sr have been used.

Where bladder tumors have been treated by infiltration with 32P.

3. Extracorporeal irradiation of blood results in a depletion lymphocytes, thereby producing an alteration in the immunologic response of the individual, 60Co sources were used. 05/04/23 13L15-16

Page 14: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

B- Internal sourcesInternal sources for radiotherapy for treatment use

six different radioisotopes:

1.Gold Au 198, used as a colloidal gold suspension in

the treatment of peritoneal and pleural effusions

associated with malignant tumors.

198 Au has also been used in the treatment of

prostate and cervical uterine carcinoma and

bladder tumors.05/04/23 14L15-16

Page 15: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

2. Sodium Phosphate P32 may be used in the

treatment of polycythemia vera to decrease the

rate of formation of the erythrocytes.

The isotope is readily distributed to all tissues and

is concentrated in those tissues where

proliferation is most rapid.

Thus cancerous tissues concentrate the greatest

amount of the isotope.

05/04/23 15L15-16

Page 16: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

3. Yttrium Y 90 is of special interest because of its

64- hour half - life.

It emits a single beta particle no gamma radiation.

90Y has a strong affinity for chelating agents.

Chelation With N- hydroxy ethylene diamine

triacetic acid (Ed-ol) will cause 90Y to localize in

the bone where it can be made to cause

predictable hematologic changes.

This chelate has been used to treat leukemia and

multiple myeloma.

05/04/23 16L15-16

Page 17: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

4. Sodium Iodide I 131 has several therapeutic

applications. In cases of hyperthyroidism,

therapeutic doses of 131I will destroy thyroid tissue

by means of radiation produced within the gland.

This procedure provides a more desirable mode of

therapy than external roentgen-ray treatment

since there is less radiation danger to the

surrounding tissues.

5. Iodine I125 with a half - life of 60 days and an

average photon energy of 28 keV is useful for

permanent implants for treatment of deep-seated

tumors such as those in the chest which are not

surgically response.

05/04/23 17L15-16

Page 18: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

Official radiopharmaceuticals used for therapeutic purposes.

Radionuclide

Chemical formUse

198AuGold Au 198 Injection Colloid

Antineoplastic

131 ISodium Iodide I 131 Solution

Antineoplastic

131 ISodium Iodide I 131 Capsules

Antipolycythemic

32 PSodium PhosphateP32 Solution

Antipolycythemic

05/04/23 18L15-16

Page 19: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

II-Diagnostic Applications of IsotopesFor diagnosis, isotopes are used as radioactive

tracers and not as radiation sources.

When radioisotopes are used for diagnosis, the

radiation dose delivered to the patient is maintained

at as low a level as possible.

This is accomplished by the choice of isotope for the

best combination of minimum half-life, minimum

retention in the body, and minimum quantity of

isotope, which will permit its detection and accurate

measurement.05/04/23 19L15-16

Page 20: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

Radioassary Methods in MedicineRadioisotope studies may be divided into different

categories:1-Activation Analysis

2-Isotope Dilution.

3-Radiometric

Analysis.

4-Functional

Radioassays.

5- Organ and tumour visualization

05/04/23 20L15-16

Page 21: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

1-Activation Analysis.An analytical technique capable of detecting and

measuring certain elements present in a specimen in

relatively low concentration if significant amounts of

radioactivity are induced by neutron irradiation.

05/04/23 21L15-16

Page 22: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

2-Isotope Dilution.The clinical application of this technique is illustrated

by its use for the measurement of blood volume.

Radioiodinated human serum albumin injected

intravenously; after 10 min injection a blood sample

is withdrawn, (a time sufficient to allow adequate

mixing of the labeled albumin in the intravascular

pool, and not long enough for metabolic activity or

leakage into extravascular pools to occur). The blood

volume is calculated from the measured decrease in

radioactivity of the injected sample upon its dilution

by the blood.

05/04/23 22L15-16

Page 23: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

3-Radiometric Analysis.Those radioassay methods which require the use of a

standard reagent having a known relationship

between chemical concentration and radiologic

concentration,

i.e., the radioactivity of a specific radioisotope per

unit volume, are called radiometric analyses.

05/04/23 23L15-16

Page 24: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

The determination of serum calcium involves the

addition of a measured excess of standard 14 C-oxalic

acid solution to an aliquot of serum.

After precipitation of calcium oxalate the radioactivity

of the precipitate is determined.

This activity is related to the calcium content of the

serum.

A variety of similar assays have been developed,

including the determination of serum citric acid by

use of 82Br.05/04/23 24L15-16

Page 25: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

4-Functional Radioassays.Radioassays utilizing radioisotopes as aid in

measuring the rate of a biological process are called

functional radioassays.

They can be divided into three categories:

i- Rate of isotope transfer.

ii-Rate of Isotope Disappearance.

iii-Metabolic Processes and/or Isotope Concentration.

05/04/23 25L15-16

Page 26: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

i- Rate of isotope transfer. In these procedures, a labeled substance is injected into one part of the vascular system and the time required for its arrival to another part is determined. This technique has been used widely to determine circulation time, especially in the extremities. 24Na is well suited for this purpose, since: it has a short half-life, is a normal body constituent,is not selectively absorbed by any tissue, and is readily detected. These methods has been used in the treatment of cardiac output.05/04/23 26L15-16

Page 27: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

ii-Rate of Isotope Disappearance. The rate at which an isotope disappears from a tissue

into which it has been injected is a measure of the

circulation in that tissue.

This test has been used successfully to determine the

extent of circulation in tubed skin grafts in plastic

surgery.

A small amount of an isotope, eg, radiosodium

chloride, is injected directly into the tissue.

The disappearance rate of the isotope is measured by

means of a counter placed directly over the site of

injection.

05/04/23 27L15-16

Page 28: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

The RBC destruction mechanism and RBC half-life are

measured by means of a disappearance - rate

technique.

If erythrocytes are labeled in vitro with 51Cr and then

reinjected, the rate of the tagged cells can be followed

by assay of serial blood samples taken every two or

three days for at least two weeks.

This study is a valuable aid in the diagnosis of

hemolytic anemia.

05/04/23 28L15-16

Page 29: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

iii-Metabolic Processes and/or Isotope Concentration.

Most of radioisotope studies are in this category. The concentration of a particular radioisotope in normal

or abnormal tissue or in an organ provides data from which the function of the tissue or the metabolic condition of the organ can be evaluated.

Several studies of thyroid function can be carried out with the aid of radioactive 131 I as Na 131 I.

These studies include:(i)The rate of deposition of iodine in the gland in vivo. (ii) The total accumulation of iodine in the gland within a

specified period of time (iii) The output of thyroid hormone into which radioactive

iodine has been incorporated.05/04/23 29L15-16

Page 30: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

The thyroid gland concentrates inorganic iodide from

the

blood and converts it to thyroxine (the thyroid

hormone),

through the action of a peroxidase enzyme.

When a thyroid gland is relatively “iodine starved",

i.e., receiving no more iodine than is found in the

normal

diet, the administration of a small dose of radioactive

iodine

results in a portion of the dose being retained by the

thyroid, while the remainder of the radioactive

isotope is

excreted in the urine.

The amount of radioactive iodine retained by the

thyroid is

an index of thyroid function.

05/04/23 30L15-16

Page 31: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

5. Organ and tumour visualization In recent year scanning have developped rapidly and

are

now among the most useful tools in diagnostic

medicine.

By means of scanning, tissues and organs can be

visualized

and such visualization facilitates the detection of

abnormalities in their function.

05/04/23 31L15-16

Page 32: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

In general a scanning technique consists of:

a- Administration of a radioactively tagged

compound .

b- Concentration of the compound in the organ or

tissue concerned

c- Scanning of the region of the organ to prepare a

contour" map of the radioactivity relating the

concentration of the radioactivity and its physical

location .

05/04/23 32L15-16

Page 33: DOSAGE FORMS AND APPLICATION OF RADIOPHARMACEUTICS

Sites of different radioactivity concentrated in the

organs are detected and visible evidence of the

pattern of radiation concentration in the area under

examination is produced in the form of a photoscan.

Dense regions in the scan are indicative of regions of

high activity.

Organs which have been mapped by such techniques,

with particular success, include the lungs, kidneys

thyroid, liver, heart, spleen, bone and brain.

05/04/23 33L15-16